Concepedia

Minhang Xin

MX

42

Publications

1.2K

Citations

20

H-Index

2009

Active since

Affiliations

Xi'an Jiaotong University(Current)

Simcere Pharmaceutical (China)

China Pharmaceutical University

Central China Normal University

Minhang Xin is an author at Xi'an Jiaotong University specializing in medicine, drug discovery, and pharmacology.

Top concepts

MedicinePharmacologyDrug DiscoveryMedicinal ChemistryPharmacotherapyBiochemistryDrug DevelopmentNatural SciencesChemical BiologyMolecular Pharmacology

Publications per year

2009–2024

42

Publications

42

Discovery of potent epidermal growth factor receptor (EGFR) degraders by proteolysis targeting chimera (PROTAC)

Hao Zhang, Hongyi Zhao, Xiao-Xiao Xi et al. · European Journal of Medicinal Chemistry · 2020 · 117 citations

Medicine, Cancer Growth, Cell Growth +5

Discovery of potent small molecule PROTACs targeting mutant EGFR

Hongyi Zhao, Xueyan Yang, Hao Lei et al. · European Journal of Medicinal Chemistry · 2020 · 86 citations

Tumor Biology, Drug Targeting, Mutant Egfr +5

Discovery of Potent PROTACs Targeting EGFR Mutants through the Optimization of Covalent EGFR Ligands

Hongyi Zhao, Haipeng Wang, Yu-Ze Mao et al. · Journal of Medicinal Chemistry · 2022 · 71 citations

Discovery of novel 9-heterocyclyl substituted 9H-purines as L858R/T790M/C797S mutant EGFR tyrosine kinase inhibitors

Hao Lei, Shu Fan, Hao Zhang et al. · European Journal of Medicinal Chemistry · 2019 · 63 citations · Full text

Molecular Pharmacology, Medicinal Chemistry, Substituted 9H-purines +9

Synthesis and anticancer effects evaluation of 1-alkyl-3-(6-(2-methoxy-3-sulfonylaminopyridin-5-yl)benzo[d]thiazol-2-yl)urea as anticancer agents with low toxicity

Xiaoxiao Xie, Huan Li, Juan Wang et al. · Bioorganic & Medicinal Chemistry · 2015 · 52 citations · Full text

Medicinal Chemistry, Pharmaceutical Science, Low Toxicity +11

Rows per page

1–5 of 42